blood monitoring

Views & Analysis

Monitoring people who are on disease modifying drugs (DMDs) is paramount to providing safe, high-quality MS care.

News

Viridian has fired a shot across Amgen's bows with the FDA approval of Tepezza rival Lumvoa in thyroid eye disease, a $2bn market.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.